Search
for
Sort by
Research 30 of 524
- Role of plasminogen activator inhibitor type 1 (PAI-1) in PCOS patient
- Oral contraceptive pill (OCP) treatment alters the gene expression of intercellular adhesion molecule-1 (ICAM-1), tumor necrosis factor-α (TNF-α), monocyte chemoattractant protein-1 (MCP-1) and plasminogen activator inhibitor-1 (PAI-1) in polycystic ovary syndrome (PCOS) women compared to drug-naive PCOS women
- Deletion of adipocyte Sine Oculis Homeobox Homolog 1 prevents lipolysis and attenuates skin fibrosis
- Ku80 as a Novel Receptor for Thymosin β4 That Mediates Its Intracellular Activity Different from G-actin Sequestering
- Wound healing in development
- Thrombin activatable fibrinolysis inhibitor and other hemostatic parameters in patients with polycystic ovary syndrome
- Evaluation of cardiac risk marker levels in obese and non-obese patients with polycystic ovaries
- Genetic basis of polycystic ovary syndrome
- Minoxidil Regulates Aging-Like Phenotypes in Rat Cortical Astrocytes <i>In Vitro</i>
- Laboratory and clinical haemostatic aberrations in primary dermatologic disease: A review
- LB821 Human hair follicle dermal papilla as an in vitro model to study stress-induced hair growth arrest
- Gene Variant in Amish a Clue to Better Aging
- Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment
- Photoacoustic Imaging as a Tool for Assessing Hair Follicular Organization
- Standardized Informed Consent Form for Clinicians Administering Platelet-Rich Plasma
- Valence-engineered catalysis-selectivity regulation of molybdenum oxide nanozyme for acute kidney injury therapy and post-cure assessment
- Localization of Plasminogen Activator Inhibitor Type 2 (PAI-2) in Hair and Nail: Implications for Terminal Differentiation
- The application of optical technology in the diagnosis and therapy of oxidative stress-mediated hepatic ischemia-reperfusion injury
- ADRENAL FAILURE: WHEN ANTIPHOSPHOLIPID SYNDROME LEAVES SCARS
- Long‐read sequencing reveals SVA insertion in <i>AP3B1</i> causing Hermansky–Pudlak syndrome 2
- Androgenetic alopecia in COVID-19: Compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign
- Immunohistochemical Expression of Sox9 and CD34 in Androgenetic Alopecia Patients
- Induction of synapse associated protein 102 expression in cyclosporin A-stimulated hair growth
- Decreased lipin 1β expression in visceral adipose tissue is associated with insulin resistance in polycystic ovary syndrome
- COVID-19 Infection and Vaccination Effects on Breast Implant Illness: A Case Report
- 708 SIG-1451: A topical anti-inflammatory new chemical entity for atopic dermatitis (AD)
- COVID‐19, androgens, and androgenic alopecia
- Male balding as a major risk factor for severe COVID-19: A possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals
- Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
- 17th national conference of association of cutaneous surgeons (I) (ACSICON 2019)––conference report